[VIDEO] Why Do Our Brains Get Addicted?

By Admin
Share
Nora Volkow is a world leader in the neurobiology of diseases of reward and self-control such as addiction and obesity. Nora was born in Mexico City, wh...

Nora Volkow is a world leader in the neurobiology of diseases of reward and self-control such as addiction and obesity. Nora was born in Mexico City, where she lived until she completed medical school.

While training as a psychiatrist in New York City, she started doing research with brain imaging technologies to study how drugs affect the human brain. Nora’s research has been instrumental in demonstrating that addiction is a brain disease that undermines the function of circuits that underlie reward, motivation and self-control - and in identifying overlapping circuitry disruptions in obesity.

[READ MORE] The World is Fat: How the Obesity Epidemic is Affecting the Global Economy

Nora is currently the Director of the National Institute on Drug Abuse at NIH, which oversees most of the world’s research on drug abuse and addiction.

In her recent talk at TEDMED, she applied a lens of addiction to the obesity epidemic.

Watch her discussion in the video below. 

Follow us on Twitter (@HealthcareGlbl) and like us on Facebook!

Share

Featured Articles

NTT & Olympus: World's First Cloud Endoscopy System

NTT and medical technology company Olympus put on a demonstration, showing the IOWN APN's low-latency capability, for the first cloud endoscopy system

Richter BioLogics' New Biopharmaceutical GMP Facility

Richter BioLogics GmbH & Co KG's a new biopharmaceutical GMP facility in Germany will boost production capabilities and local employment

GE HealthCare's Pilot Study Shows Value of Portrait Mobile

A pilot study from GE Healthcare has shown the value of Portrait Mobile Continuous Monitoring Solution, a leap in post-surgical monitoring efficiency

50% of Teens to be Affected by Myopia Globally by 2050

Telehealth & COVID-19

NVIDIA’s AI Insights for Diabetes Prevention with GluFormer

Technology & AI

Novo Nordisk's CagriSema Next Gen Weight-Loss Treatment

Medical Devices & Pharma